Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy.
Diabetology, Catholic University, Rome, Italy.
Bone. 2019 Aug;125:194-199. doi: 10.1016/j.bone.2019.04.017. Epub 2019 May 3.
To determine clinical diabetes-related risk factors for fragility fractures in type 1 diabetes (T1D).
History of bone fragility fractures occurring after T1D diagnosis was assessed by questionnaire in this cross-sectional study in 600 T1D subjects. Glycated hemoglobin A1c (HbA1c) over the previous 5 years was used as an index of long-term glycemic control; complications were adjudicated by physician assessment. Multinomial logistic regression models were used to assess the associations between diabetes-related risk factors and fracture history.
One-hundred-eleven patients (18.5%) reported at least one fracture; of these 73.8% had only one and 26.2% had more than one fracture. Average age was 41.9 ± 12.8 years, with even gender distribution; disease duration was 19.9 ± 12.0 years; and BMI was 24.4 ± 3.7 kg/m. The 5-year average HbA1c was 7.6 ± 1.0% (60 mmol/mol). In adjusted models, reduced risk for 1 fracture was found in those with higher creatinine clearance rate (CCr) (RRR 0.22 [95% CI: 0.06-0.83] for 1 unit increase in lnCCr, p = 0.03) and increased risk in those with neuropathy (RRR 2.57 [1.21-5.46], p = 0.01). Increased risk for ≥2 fractures was found in subjects in the highest tertile of HbA1c (≥7.9%) compared with the lowest tertile (≤7.17%) (RRR 3.50 [1.04-11.7], p = 0.04) and of disease duration (≥26 years versus <14 years) (RRR 7.59 [1.60-35.98], p = 0.01).
Poor glycemic control and long exposure to the disease are independent diabetes-related risk factors for multiple bone fractures in T1D.
确定 1 型糖尿病(T1D)患者中与临床糖尿病相关的脆性骨折风险因素。
本研究为横断面研究,共纳入 600 例 T1D 患者,通过问卷调查评估 T1D 诊断后骨脆性骨折的发生史。过去 5 年的糖化血红蛋白 A1c(HbA1c)用作长期血糖控制的指标;并发症由医生评估。采用多项逻辑回归模型评估糖尿病相关危险因素与骨折史之间的关系。
111 例(18.5%)患者报告至少发生过 1 次骨折;其中 73.8%的患者仅有 1 次骨折,26.2%的患者有多处骨折。患者平均年龄为 41.9±12.8 岁,性别分布均衡;病程为 19.9±12.0 年;体重指数为 24.4±3.7 kg/m2。过去 5 年的平均 HbA1c 为 7.6±1.0%(60 mmol/mol)。在调整后的模型中,发现估算肾小球滤过率(CCr)较高的患者发生 1 次骨折的风险降低(lnCCr 每增加 1 单位,RRR 为 0.22 [95%CI:0.06-0.83],p=0.03),而患有神经病变的患者发生 1 次骨折的风险增加(RRR 为 2.57 [1.21-5.46],p=0.01)。与最低三分位(≤7.17%)相比,HbA1c 最高三分位(≥7.9%)的患者发生≥2 次骨折的风险增加(RRR 为 3.50 [1.04-11.7],p=0.04),病程较长(≥26 年与<14 年)的患者发生≥2 次骨折的风险增加(RRR 为 7.59 [1.60-35.98],p=0.01)。
血糖控制不佳和长期患病是 T1D 患者发生多处骨折的独立糖尿病相关危险因素。